NCT06571669ClinicalTrials.gov

BOOM-IBD2 Pivotal Clinical Trial

BOOM-IBD2 Clinical Trial to Evaluate the Effectiveness of Sacral Neuromodulation for the Treatment of IBD.

RecruitingTaking participants now, according to the registry record.

Contact this study

In brief

Ulcerative colitis is a long-lasting condition that causes swelling and sores in the large intestine. This study tests whether a small device placed under the skin can help reduce bowel urgency in people with ulcerative colitis. The investigational device sends…

Interventional137 participants sought19 sites1 country

Registered in 1 registry

ClinicalTrials.govNCT06571669Open this record at ClinicalTrials.govSynced last month

One study can be registered in several registries. We show it once and link every record we hold.

Trial information is shown as published by the registry, in its original language.

Interested in this study?

How this study is set up

The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.

Present: Registered before enrolment beganFirst posted 2024-08-26; recorded start 2025-01-31
Present: Has a defined primary outcomeA primary outcome measure is listed in the record
Present: The primary outcome states a time frameThe primary outcome measure records a time frame
Not stated: Participants are not randomly assignedAllocation is recorded as non-randomised
Not stated: A comparison group is not stated in the registry recordThe record describes a single study arm
Not stated: Open label (no blinding)Masking is recorded as none (open label)
Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
Not stated: No other studies from this sponsor are in this databaseCounted from the lead sponsor named in the record (Boomerang Medical)
Not stated: No posted results from this sponsor are in this database yetBased on the sponsor’s studies in this database

The record lists 2 conditions.
Lead sponsor type recorded as: industry.

These are facts from the public registry record, not a judgement about the study. Discuss any trial with your own doctor before taking part.

What these facts mean, and what to ask · ruleset v1

Trial stature

Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.

Methodological rigourEXPLORATORY

An exploratory-stage design for a study of this type, judged from its ClinicalTrials.gov record.

How this score is built

Randomised allocation0/20
Allocation not stated in the record
Blinding0/20
Open-label
Control arm0/15
No comparator arm stated in the record
Primary-outcome specificity10/10
Named primary outcome with a defined time frame
Endpoint type3/10
Surrogate or intermediate endpoint (conservative default)
Multi-centre8/8
Multi-centre: 19 sites
Data monitoring committee0/7
No data monitoring committee stated
Prospective registration5/5
Registered before the study start date
Protocol / SAP posted0/5
No protocol or SAP posted to the registry

ScaleSMALL

A small study: 137 participants (target), run at 19 sites.

How this score is built

Enrolment20/40
137 participants (target)
Site count15/25
19 sites
Country count0/15
Single country
Planned duration8/10
Planned over about 34 months
Sponsor scale0/10
Boomerang Medical has led 1 trials in our corpus

Investigator standingUNKNOWN

We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.

How this score is built

Investigator standing0/100
No investigator recorded in the registry for this trial

These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.

Summary

The main goal is to find out if bowel urgency gets better after 12 weeks, using a standard rating scale for bowel urgency. Adults ages 18 to 85 with ulcerative colitis may be able to join. Everyone in the study gets the device. There is no placebo group. Study visits continue for 12 months.

Conditions

Ulcerative Colitis
Inflammatory Bowel Diseases

Eligibility

Eligibility
Sex	All
Ages	18 Years – 85 Years
Healthy volunteers	No

Eligibility as written in the registry

Inclusion Criteria: * Male or female * 18 to 85 years of age * Diagnosed with ulcerative colitis * Ability and willingness to consent to participate by signing the informed consent form * Ability to comply with the protocol and willingness to comply with all follow up requirements Exclusion Criteria: * Any significant medical condition that is likely to interfere with study procedures, device operation, or likely to confound the results of the study * Any psychiatric or personality disorder at the discretion of the study investigator * Any active bacterial infection with a risk of bacteremia or sepsis (e.g. presence of abscess) * Active clostridium difficile infection of the colon * Active cytomegalovirus (CMV) infection of the colon * Evidence of colonic perforation * Fulminant colitis requiring emergency surgery * Microscopic, ischemic or infectious colitis * Unresected neoplasia of the colon * Colonic stricture unable to pass a colonoscope * Current evidence of cancer in the gastrointestinal tract * Current participation in another clinical trial * Previous history of surgery for ulcerative colitis, or probably to require such intervention * Previously implanted with a neurostimulation device or participated in a neurostimulation trial * Inability to operate the patient programmer

Eligibility in plain statements

This record's criteria have not been broken into separate statements yet. The registry text above is complete and is the authoritative version.

Study design

Study design
Study type	Interventional
Phase	Not applicable
Allocation	Not applicable
Intervention model	SINGLE_GROUP
Primary purpose	TREATMENT
Masking	NONE (0)
Enrolment	137 participants sought

Sponsor and collaborators

Boomerang Medical Sponsor

Arms and interventions

Treatment ArmEXPERIMENTAL
Patients implanted with neuromodulation

Interventions

Device Neuromodulation
Neuromodulation

Outcome measures

Primary outcome
Bowel Urgency
Bowel urgency at 12 weeks using the urgency numeric rating scale (URNS). The Urgency NRS is a patient-reported outcome (PRO) that quantifies the severity of bowel urgency on a scale from 0 to 10, where 0 equals no bowel urgency and 10 equals worst possible urgency.
Time frame 12 weeks

Dates

Dates
Start date	January 31, 2025 (actual)
Primary completion	February 28, 2027 (estimated)
Completion	November 30, 2027 (estimated)
First posted	August 26, 2024 (actual)
Last updated	August 6, 2026
Results posted	Not stated in the registry record
Status last verified	August 2026

Actual means the event happened. Estimated means the sponsor expects it. The two mean different things.

Locations

16 sites are recruiting

United States

United States
Facility	City	State or region	Status
Amarillo Premier Research (Objective Health)	Amarillo	Texas	Recruiting
UNC Chapel Hill	Chapel Hill	North Carolina	Recruiting
Columbia Digestive Health Research (Objective Health)	Columbia	South Carolina	Recruiting
Gastroenterology Medical Clinic (Objective Health)	Folsom	California	Recruiting
GI Alliance	Jackson	Mississippi	Recruiting
Las Vegas Medical Research LLC, DBA Vector Clinical Trials	Las Vegas	Nevada	Recruiting
Center for Colorectal Innovation	Los Angeles	California	Recruiting
Northwell Health North Shore University Hospital	Manhasset	New York	Recruiting
Great Lakes Gastro	Mentor	Ohio	Withdrawn
Columbia University Irving Medical Center/New York Presbyterian Hospital	New York	New York	Recruiting
Hoag Hospital	Newport Beach	California	Recruiting
PAMF (Palo Alto Medical Foundation)	Palo Alto	California	Recruiting
Pennsylvania Hospital	Philadelphia	Pennsylvania	Not yet recruiting
Sanford Health	Sioux Falls	South Dakota	Recruiting
Gateway GI Research (Objective Health)	St Louis	Missouri	Recruiting
Digestive Research of Central Texas (Objective Health)	Waco	Texas	Recruiting
Kansas Gastro	Wichita	Kansas	Recruiting
Digestive Health Research of North Texas (Objective Health)	Wichita Falls	Texas	Active, not recruiting
MN Urology	Woodbury	Minnesota	Recruiting

Study documents

No documents are linked in this registry record.

Changes over time

No changes have been recorded since we first ingested this record.

A change is recorded each time the sponsor updates the registry record. Status, dates, enrolment and sites appear here as they move.

Registry: ClinicalTrials.gov · NCT########

https://xmedica.io/trials/ctgov/NCT06571669

Categories

Registered in 1 registry

Interested in this study?

How this study is set up

Summary

Conditions

Eligibility

Eligibility as written in the registry

Eligibility in plain statements

Study design

Sponsor and collaborators

Arms and interventions

Interventions

Outcome measures

Dates

Locations

United States

Study documents

Changes over time